Esomeprazole and omeprazole may well boost the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) bringing about increased adverse effects like drowsiness, although the clinical relevance is low in most patients – monitor the affected individual for adverse effects (e.The goal of this research was to evaluate the anxiolytic,